Elanco Animal Health (ELAN) Stock Forecast & Price Target
Elanco Animal Health · NYSE
$25.50+0.10 (+0.37%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 10 firms covering Elanco Animal Health, 9 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $23.00 to $32.00, so the covering firms are broadly aligned. The average target of $28.80 sits 13% above the current $25.50. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.19 next quarter toward $1.20 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS10 ratings
Moderate Buy
Strong Buy00%
Buy990%
Hold110%
Sell00%
Strong Sell00%
Based on 10 analysts giving stock ratings to Elanco Animal Health.
As of Jul, 9 of 10 firms rate ELAN a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ELAN EPS & revenue forecast
EPS · NEXT QUARTER
$0.19
Range $0.18 – $0.21 · 11 analysts · +2% YoY
Next period, 11 analysts expect Elanco Animal Health to earn $0.19 a share (range $0.18 – $0.21), versus $0.19 a year earlier. Full-year consensus is $1.07, growing to $1.20 the year after.
REVENUE · NEXT QUARTER
$1.2B
Range $1.2B – $1.2B · 11 analysts · +5% YoY
Revenue is expected to reach $1.2B (range $1.2B – $1.2B), +4.8% year-over-year. Full-year consensus is $5.1B, rising to $5.3B next year.
Top analysts covering Elanco Animal Health
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ELAN.
#1
Balaji Prasad
Barclays · Rank #147
Buy
$19.00-25.5% to target
Overall win rate
44%
+ Follow
#2
Jonathan Block
Stifel · Rank #172
Buy
No targeton ELAN
Overall win rate
42%
+ Follow
#3
David Westenberg
Piper Sandler · Rank #227
Buy
$30.00+17.6% to target
Overall win rate
31%
+ Follow
#4
Scott Schoenhaus
Keybanc · Rank #345
Buy
$29.00+13.7% to target
Overall win rate
29%
+ Follow
#5
AA
Andrea Alfonso
UBS
Buy
$31.00+21.5% to target
Coverage
—
+ Follow
ELAN stock forecast FAQ
What is ELAN's average 12-month price target?+
The 10 analysts with a live target average $28.80 for Elanco Animal Health over the next 12 months, ranging from a $32.00 high to a $23.00 low.
Is ELAN stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 10 analyst ratings, 9 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for ELAN?+
The Street-high target is $32.00 (TD Cowen), and the Street-low is $23.00 (Stifel). The average of all 10 active targets is $28.80.
How many Wall Street analysts cover ELAN?+
10 analysts have an active rating on Elanco Animal Health, and 10 firms carry a live 12-month price target.
Who is the most accurate analyst covering ELAN?+
Among analysts who currently cover ELAN, Balaji Prasad of Barclays has the strongest overall Quantellect track record (Rank #147). Their current call is Buy with a $19.00 target.
What is Elanco Animal Health's projected EPS for next quarter?+
The consensus estimate is $0.19 per share (range $0.18 – $0.21) across 11 analysts. Full-year EPS is projected at $1.07, rising to $1.20 the following year.
How much revenue is Elanco Animal Health expected to report next quarter?+
Consensus revenue is $1.2B (range $1.2B – $1.2B). Full-year revenue is projected at $5.1B, growing to $5.3B next year.
Have analysts been upgrading or downgrading ELAN lately?+
As of Jul, 9 of 10 firms rate ELAN a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ELAN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
